Skip to content
Catalyst

inosineFinding

Inosine has no detected effect on body mass index

no difference foundModerate evidenceFinding

01 · The sentence it was drawn from

“For example, serial vital signs, serum assays and ECGs showed no effect of inosine on blood pressure (eTables 5 and 6), body mass index (BMI; eTable 7), serum glucose and cholesterol (eTables 8), or electrocardiographic parameters (eTable 9).”
Quoted verbatim from Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.
This finding among the 96 findings on its endpoint

inosine

Body mass index

no difference found

Who
Adults with early Parkinson disease not yet requiring symptomatic treatment, serum urate below about 6 mg/dL, without gout, urolithiasis, or cardiovascular or renal disease, at US Parkinson Study Group sites; both inosine arms (titrated to mild or moderate serum urate elevation) against placebo; hydration encouraged in all arms
Dose studied
inosine 500 mg capsules, started at 1 capsule twice daily and titrated up to 2 capsules three times daily (maximum 3 g/day) to serum urate 6.1-7.0 or 7.1-8.0 mg/dL; mean doses 1.18 and 1.51 g/day; up to 24 months

Moderate evidencePMID 24366103 · 2014

02 · The study

Study
RCT
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7GGMA894R254NPPAXDPC41N